Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 12, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 31
- 0 vs. Q4 2022
- Portfolio value
- $412.5M
- −$24.9M (−5.7%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| GILDGilead Sciences, Inc. | Stock | 542,773 | $45.0M | 10.9% | −53,263−8.9% | Reduced | History |
| INCYIncyte Corp | COM | 432,235 | $31.2M | 7.6% | +20,748+5.0% | Added | History |
| BMYBristol Myers Squibb Co | Stock | 449,571 | $31.2M | 7.6% | +71,902+19.0% | Added | History |
| CAHCardinal Health Inc | Stock | 376,701 | $28.4M | 6.9% | +22,829+6.5% | Added | History |
| MDTMedtronic plc | Stock | 318,904 | $25.7M | 6.2% | +41,469+14.9% | Added | History |
| BIIBBiogen Inc. | COM | 87,836 | $24.4M | 5.9% | +17,797+25.4% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 176,103 | $22.8M | 5.5% | +21,987+14.3% | Added | History |
| LHLabcorp Holdings Inc. | COM NEW | 81,415 | $18.7M | 4.5% | +6,919+9.3% | Added | History |
| ELVElevance Health, Inc. | Stock | 35,779 | $16.5M | 4.0% | −11,998−25.1% | Reduced | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 156,350 | $15.2M | 3.7% | +1,341+0.9% | Added | History |
| CNCCentene Corp | Stock | 238,746 | $15.1M | 3.7% | +53,845+29.1% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 158,806 | $13.1M | 3.2% | −15,446−8.9% | Reduced | History |
| BRKRBruker Corp | COM | 153,117 | $12.1M | 2.9% | −38,865−20.2% | Reduced | History |
| QGENQiagen N.V. | SHS NEW | 260,787 | $12.0M | 2.9% | +27,314+11.7% | Added | History |
| CTLTCatalent, Inc. | COM | 150,501 | $9.89M | 2.4% | +95,501+173.6% | Added | History |
| THCTenet Healthcare Corp | COM NEW | 165,227 | $9.82M | 2.4% | −30,727−15.7% | Reduced | History |
| NUVANuvasive Inc | COM | 233,756 | $9.66M | 2.3% | +59,914+34.5% | Added | History |
| BSXBoston Scientific Corp | Stock | 162,397 | $8.12M | 2.0% | −132,387−44.9% | Reduced | History |
| SGENSeagen Inc. | COM | 36,000 | $7.29M | 1.8% | −70,207−66.1% | Reduced | History |
| BAXBaxter International Inc | Stock | 167,000 | $6.77M | 1.6% | −54,088−24.5% | Reduced | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 13,617 | $6.52M | 1.6% | −2,371−14.8% | Reduced | History |
| MRKMerck & Co., Inc. | Stock | 56,153 | $5.97M | 1.4% | −143,147−71.8% | Reduced | History |
| ILMNIllumina, Inc. | COM | 23,677 | $5.51M | 1.3% | −23,823−50.2% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 27,389 | $5.49M | 1.3% | +27,389 | New | History |
| IONSIonis Pharmaceuticals Inc | COM | 146,441 | $5.23M | 1.3% | +5,068+3.6% | Added | History |
| ACADAcadia Pharmaceuticals Inc | COM | 232,718 | $4.38M | 1.1% | +46,883+25.2% | Added | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 106,282 | $4.26M | 1.0% | +60,762+133.5% | Added | History |
| VIRVir Biotechnology, Inc. | COM | 145,545 | $3.39M | 0.8% | +55,737+62.1% | Added | History |
| BNTXBioNTech SE | SPONSORED ADS | 26,554 | $3.31M | 0.8% | +2,816+11.9% | Added | History |
| CVSCVS Health Corp | Stock | 38,310 | $2.85M | 0.7% | −5,133−11.8% | Reduced | History |
| PTCTPTC Therapeutics, Inc. | COM | 54,906 | $2.66M | 0.6% | −31,786−36.7% | Reduced | History |
Sold out since Q4 2022 (1)
Positions held at the end of Q4 2022 that are gone from this filing.